Kymera Therapeutics, Inc. · NASDAQ:KYMR

BVF PARTNERS L P/IL reported a 8.50% stake in Kymera Therapeutics, Inc. (Schedule 13D/A)

Event Dec 11, 2025 · Filed Dec 15, 2025

BVF PARTNERS L P/IL reported a 8.50% stake in Kymera Therapeutics, Inc., 6,867,809 shares, with active intent on Dec 11, 2025. Filed Dec 15, 2025 (Schedule 13D/A).

Stake
8.50%
Shares
6,867,809
Intent
Active
What changed
Stake changed
Filed together
11 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P4.40%3,550,766
BVF I GP LLC4.40%3,550,766
BIOTECHNOLOGY VALUE FUND II LP3.40%2,752,456
BVF II GP LLC3.40%2,752,456
Biotechnology Value Trading Fund OS LP0.50%406,145
BVF Partners OS Ltd.0.50%406,145
BVF GP HOLDINGS LLC7.80%6,303,222
BVF PARTNERS L P/IL8.50%6,867,809
BVF INC/IL8.50%6,867,809
LAMPERT MARK N8.50%6,867,809
Hrustanovic Gorjan0.10%100,190

Source

View original at SEC

Related